Manufacture, formulation and dosing of apraglutide
AssigneeVectivBio AG
InventorsFederico Bolognani, Gleb Feldman, Jean-Marie Receveur, Torsten Weiss
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to methods of making, formulating and administering GLP-2 analogs.
Claims32
A method of treating short bowel syndrome (SBS) in a human subject, the method comprising administering an aqueous pharmaceutical composition comprising apraglutide, or a pharmaceutically acceptable salt thereof, to the human subject once weekly by subcutaneous injection, wherein the apraglutide is at a dose between 1 mg and 10 mg.
A method of treating short bowel syndrome (SBS) in a human subject, the method comprising subcutaneously administering a once weekly dose of between 1 mg and 10 mg apraglutide to the human subject in an aqueous pharmaceutical composition.
Dependencies are inferred from the claim text.